Most people who use Mounjaro (tirzepatide) for weight loss stay on it indefinitely. The FDA approved the weight-loss version of this drug, Zepbound, specifically for long-term use, and clinical trial data shows that stopping the medication leads to significant weight regain within a year. While some people hope to use it as a short-term kickstart, the evidence points toward ongoing treatment for most.
Why It’s Considered a Long-Term Medication
The FDA label for Zepbound (the weight-loss brand of tirzepatide) states the drug is indicated “to reduce excess body weight and maintain weight reduction long term.” That language is deliberate. Obesity medicine specialists treat excess weight as a chronic condition, similar to high blood pressure or high cholesterol, where medication manages the problem rather than curing it.
Tirzepatide works by mimicking two gut hormones that reduce hunger and increase feelings of fullness. It doesn’t permanently reset your appetite. It suppresses it for as long as you take the drug. Once the medication leaves your system, those hunger signals return to their previous levels, and the biological drive to regain weight kicks back in.
What Happens When You Stop
The SURMOUNT-4 trial provides the clearest picture. Researchers took participants who had lost at least 10% of their body weight after 36 weeks on tirzepatide, then randomly assigned half of them to continue the drug and half to switch to a placebo. The results after one year off the medication were stark: 82% of the placebo group regained more than 25% of the weight they had lost. Nearly a quarter of them regained 75% or more of their lost weight. Only about 1 in 6 participants kept most of the weight off without the drug.
A systematic review published in The BMJ helps explain why. These medications make behavior change easier by suppressing hunger and boosting satiety. But that also means the healthy eating patterns people develop while on the drug become much harder to maintain once the pharmacological support disappears. Diet and exercise alone, which are “the only recourse after cessation,” often can’t counteract the body’s powerful drive to restore its previous weight.
The Typical Treatment Timeline
Mounjaro and Zepbound follow a dose-escalation schedule during the first several months. You start at the lowest dose and increase every four weeks, allowing your body to adjust and minimizing side effects like nausea. Reaching the target dose typically takes around 20 weeks, though your prescriber may slow the timeline if side effects are bothersome.
Weight loss tends to be most rapid during the first six to nine months. After that, most people hit a plateau where their weight stabilizes. This is the maintenance phase, and it’s where the question of “how long” really matters. For the majority of users, this maintenance phase has no planned end date. You continue the medication at whatever dose keeps your weight stable, which may be lower than the maximum dose you used during active weight loss.
Some prescribers will try reducing the dose during maintenance to find the lowest effective amount. Others keep patients at the dose where weight loss plateaued. There’s no single correct approach, and this is something you’d work out over time based on how your body responds.
Insurance Renewal and Coverage Gaps
Even if the medical plan is indefinite treatment, insurance coverage often works in shorter increments. Many insurers require prior authorization every three to six months, and renewal typically depends on showing continued progress. One common threshold is a 5% reduction in body weight compared to your weight at the most recent authorization. If you’ve already lost a significant amount and your weight has stabilized, meeting that threshold for renewal can become tricky, since the expectation of ongoing loss may not match the reality of maintenance.
Coverage policies vary widely between insurers. Some employer plans exclude weight-loss medications entirely. Others cover them but impose step-therapy requirements, meaning you have to try cheaper options first. These coverage decisions, not medical ones, are often what force people to stop treatment or switch medications. If your insurance changes or your plan drops coverage, you may face out-of-pocket costs that run over $1,000 per month at retail price.
Can You Ever Stop Taking It?
A small minority of people do maintain their weight loss after stopping. In the SURMOUNT-4 trial, about 18% of participants who switched to placebo regained less than 25% of what they had lost. Researchers haven’t yet identified reliable predictors of who will fall into that group. People who made substantial, lasting changes to their eating habits and physical activity levels while on the medication may have a better chance, but the data on this is limited.
Some people and their doctors choose a planned discontinuation as a trial run. The idea is to stop the medication, monitor weight closely for a few months, and restart if regain begins. This can work as a strategy for testing whether you’re one of the people who can maintain without the drug, but it requires close follow-up and a willingness to resume treatment quickly.
The honest answer for most people is that tirzepatide works best as an ongoing treatment. The weight it helps you lose stays off as long as you keep taking it. Viewing it as a temporary fix sets up unrealistic expectations and, for the majority of users, leads to regaining most or all of the lost weight within a year of stopping.